[ASAP] Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer 🔗 Access full article via ACS Journal of Medicinal ChemistryAI SummarySummary Unavailable.Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
